ResMed Inc (RMD) stock
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$239.53+0.64 (+0.27%)
Close on Nov 13, 2026Market cap $33.69BP/E 21.8Yield 1.00%
ResMed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ResMed's ebitda for the twelve months ending Sep 30, 2026 was $2.09B, up 7.3% year over year. For fiscal 2026 it was $2.09B, up 10.8% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $2.09B in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.09B | +10.8% |
| FY2025 | Jun 30, 2025 | $1.88B | +25.9% |
| FY2024 | Jun 30, 2024 | $1.50B | +15.4% |
| FY2023 | Jun 30, 2023 | $1.30B | +11.8% |
| FY2022 | Jun 30, 2022 | $1.16B | +9.4% |
| FY2021 | Jun 30, 2021 | $1.06B | +9.9% |
| FY2020 | Jun 30, 2020 | $964.51M | +32.1% |
| FY2019 | Jun 30, 2019 | $730.06M | +10.3% |
| FY2018 | Jun 30, 2018 | $661.79M | +23.0% |
| FY2017 | Jun 30, 2017 | $537.96M | +4.3% |
| FY2016 | Jun 30, 2016 | $515.80M | +6.9% |
| FY2015 | Jun 30, 2015 | $482.29M | +0.8% |
| FY2014 | Jun 30, 2014 | $478.54M | +10.5% |
| FY2013 | Jun 30, 2013 | $433.10M | +13.9% |
| FY2012 | Jun 30, 2012 | $380.26M | +12.7% |
| FY2011 | Jun 30, 2011 | $337.54M | +11.8% |
| FY2010 | Jun 30, 2010 | $301.95M | +23.6% |
| FY2009 | Jun 30, 2009 | $244.27M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $494.73M | +0.1% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $493.49M | -4.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $558.79M | +18.9% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $541.55M | +16.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $494.24M | +14.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $518.17M | +22.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $469.94M | +12.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $463.68M | +45.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $432.04M | +29.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $424.89M | +31.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $418.06M | +21.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $319.88M | +0.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $333.93M | +7.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $322.03M | +10.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $345.03M | +24.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $317.96M | +9.8% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $312.01M | +3.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $292.81M | +5.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $276.57M | +5.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $289.50M | +10.4% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $301.02M | +17.4% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $278.36M | +6.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $263.41M | +2.6% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $262.30M | +10.7% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $256.36M | +22.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $261.76M | +59.9% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $256.76M | +29.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $236.93M | +22.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $209.06M | +19.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $163.67M | -8.4% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $198.73M | +19.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $193.11M | +10.1% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $174.56M | +22.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $178.59M | +14.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $165.68M | +21.9% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $175.39M | +40.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $142.13M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $155.53M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $135.88M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $124.62M | – |
See a number that looks wrong?